Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in PSNL — Personalis, Inc.

CIK 1362033 LONDON, X0
Back to PSNL Full portfolio

Position in PSNL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$579,469
+$56,015 QoQ
Shares Held
43,244
-47.4% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#84
of 157 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PSNL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names. PSNL ranks #13 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NTRA
Natera, Inc.
 11,336 $3,077,157
2 TMO
Thermo Fisher Scientific Inc.
 4,702 $2,357,394
3 GH
Guardant Health, Inc.
 11,811 $1,772,004
4 BDSX
Biodesix Inc
 46,989 $1,059,601
5 DGX
Quest Diagnostics Inc
 4,971 $1,053,603
6 IDXX
Idexx Laboratories Inc /De
 1,981 $1,042,877
7 XGN
Exagen Inc.
 214,721 $998,452
8 MTD
Mettler Toledo International Inc/
 619 $790,778

All Filings in PSNL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $579,469 43,244
2026-03-31 $523,454 82,175
2025-09-30 $301,178 46,193
2025-06-30 $814,187 124,114
2025-03-31 $507,781 144,667
2024-12-31 $499,010 86,334
2024-09-30 $667,561 124,082
2024-06-30 $499,444 426,876
2024-03-31 $626,010 420,141
2023-12-31 $830,850 395,643
2023-09-30 $166,203 137,358
2023-06-30 $57,403 30,534
2022-12-31 $310,016 156,574
2022-09-30 $447,507 150,676
2022-06-30 $385,378 111,704
2022-03-31 $821,055 100,251
2021-12-31 $1,272,027 89,140
2021-09-30 $949,763 49,364
2021-06-30 $215,454 8,516